Triclabendazole
Who holds supplier records for Triclabendazole? 6 organisations hold a current record for Triclabendazole: an active US FDA Type II Drug Master File or a CEP. 3 of them hold a valid EU Certificate of Suitability. Recorded organisation countries for current records: India (6).
Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 16 Nov 2026. How we read these records
Cite as: PharmaTek, “Triclabendazole: DMF and CEP holder records”, record as of 16 Nov 2026, pharmatek.co.uk/directory/api/triclabendazole
Reading the evidence
- 6 current records
Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.
- Most recorded organisations are in India
6 of the 6 current records with a recorded country list India. Organisation country is not necessarily the manufacturing site.
- No company-level GMP certificate matched
No current EU or UK GMP certificate was matched to these organisations. That is not a negative finding; ask each candidate for its certificate and latest inspection outcome.
Current records (6)
Organisations holding an active US FDA Type II Drug Master File or a CEP for Triclabendazole. Country is the organisation's recorded country, not necessarily the manufacturing site.
- ALIVIRA ANIMAL HEALTH LTD (A GROUP CO OF SEQUENT SCIENTIFIC LTD)IndiaActive DMF 31790 · latest filing Apr 2018
- AUTHENTERRA HEALTHCARE LLPIndiaActive DMF 43383 · latest filing Jan 2026
- AZICO BIOPHORE INDIA PVT LTDIndiaActive DMF 37483 · latest filing Oct 2022
- IndiaCEP
- IndiaCEP
- IndiaCEP
The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.
Valid CEP holder entries (3)
Certificates of Suitability on the EDQM register for Triclabendazole, including the salts, esters and hydrates the register lists separately; each row shows the substance as named on the certificate. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer. 5 certificates in total, including withdrawn, expired, suspended and repeat certificates.
| Holder | Country | Certificate | Issued | EU GMP at holder's address |
|---|---|---|---|---|
| ALIVIRA ANIMAL HEALTH LIMITED Visakhapatnam | IN | CEP 2026-005 - Rev 00 Triclabendazole for veterinary use, Process-III | Jun 2026 | — |
| NGL FINE-CHEM LIMITED Mumbai | IN | CEP 2022-025 - Rev 00 Triclabendazole for veterinary use | Jun 2024 | — |
| RAKSHIT DRUGS PVT. LTD. Hyderabad | IN | CEP 2021-380 - Rev 00 Triclabendazole for veterinary use | Oct 2023 | — |
The GMP column shows the most recent EU GMP certificate issued for the same address as the holder, joined on the EMA location identifier printed on both documents (EudraGMDP, re-read about once a quarter; withdrawn certificates are excluded). A dash means no certificate carries that identifier, not that the site is uninspected. The holder's address is not necessarily where the substance is made.
Certification Online Database. European Directorate for the Quality of Medicines & HealthCare (EDQM), Council of Europe, (2026), URL: https://extranet.edqm.eu/publications/recherches_CEP.shtml. Accessed 16 Nov 2026. Reproduced with permission and unaltered. The EDQM and the Council of Europe accept no liability for any consequence arising from its use.
US product patents and exclusivity
The FDA Orange Book lists patents and exclusivities for specific approved products (1 listed product contain Triclabendazole). The latest listed exclusivity ended 13 Feb 2026. These dates are product-specific: they can cover a formulation, a combination or a method of use, and do not on their own show whether the ingredient is protected or whether generics are already approved. Check the individual product entries before planning a launch.
Overview
Triclabendazole is a small molecule active pharmaceutical ingredient (ChEMBL CHEMBL1086440).
Chemical identity
- IUPAC name
- 6-chloro-5-(2,3-dichlorophenoxy)-2-methylsulfanyl-1H-benzimidazole
- Canonical SMILES
- CSC1=NC2=CC(=C(C=C2N1)Cl)OC3=C(C(=CC=C3)Cl)Cl
- InChIKey
- NQPDXQQQCQDHHW-UHFFFAOYSA-N
- Synonyms
- EGA230B, Egaten, Egaten tm, Fasinex, NSC-759250, NVP-EGA230, Triclabendazol, Triclabendazole, Triclabendazolum, RefChem:58513, Triclabendazole Micronized, P02BX04
Pharmacologic class
As the US FDA states it for this active substance on product listings.
- Established pharmacologic class
- Anthelmintic
- Mechanism of action
- Cytochrome P450 1A2 Inhibitors; Cytochrome P450 2A6 Inhibitors; Cytochrome P450 2B6 Inhibitors; Cytochrome P450 2C19 Inhibitors; Cytochrome P450 2C8 Inhibitors; Cytochrome P450 2C9 Inhibitors; Cytochrome P450 2D6 Inhibitors; Cytochrome P450 3A Inhibitors
- Chemical structure
- Anthelmintics
Record history
No change to the current records between 13 Nov 2026 and 16 Nov 2026.
Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week
What these records establish
- An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
- A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
- Historical records show a past filing, not current supply.
- Company GMP certificates are matched to the organisation, not to the site making this substance.
- A substance missing from these registers is not evidence that no supplier exists.
Frequently asked questions
Which organisations hold current supplier records for Triclabendazole?
6 organisations hold an active US FDA Type II Drug Master File or a CEP for Triclabendazole: ALIVIRA ANIMAL HEALTH LTD (A GROUP CO OF SEQUENT SCIENTIFIC LTD) (India), AUTHENTERRA HEALTHCARE LLP (India), AZICO BIOPHORE INDIA PVT LTD (India), Alivira Animal Health Limited (India), Ngl Fine Chem Limited (India) and RAKSHIT DRUGS PVT LTD (India). A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.
Which Triclabendazole Drug Master Files are active?
ALIVIRA ANIMAL HEALTH LTD (A GROUP CO OF SEQUENT SCIENTIFIC LTD) (DMF 31790), AUTHENTERRA HEALTHCARE LLP (DMF 43383) and AZICO BIOPHORE INDIA PVT LTD (DMF 37483). The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.
Does Triclabendazole have a European Certificate of Suitability?
Yes. 3 organisations hold a valid CEP for Triclabendazole on the EDQM register, including ALIVIRA ANIMAL HEALTH LIMITED Visakhapatnam (IN), NGL FINE-CHEM LIMITED Mumbai (IN) and RAKSHIT DRUGS PVT. LTD. Hyderabad (IN). A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer.
How do I qualify a Triclabendazole supplier?
Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.
Do you supply Triclabendazole?
Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.